ADC赛道持续火热,2025年医药投并购交易拉开序幕

第一财经
10 Jan

1月13日,医药行业最具影响力的全球投资大会摩根大通医疗保健大会(JPM大会)将在美国旧金山开幕。这也是医药行业寻求并购及许可交易的重要契机。大会将吸引来自全球的跨国制药巨头与中国的生物药企高管参加。  再鼎医药、科伦博泰等中国生物医药公司已确认高管将出席下周的JPM大会。就在会议召开前,1月10日,再鼎医药与宜联生物宣布达成一项新的战略合作和全球许可协议,利用宜联生物医药的抗体偶联药物(ADC)...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10